Bonaventure Siborurema has been a community health worker for twelve years. People in his village put their trust in him and affectionately call him “Muganga” or health worker in ikinyarwanda. While he is helping his community stay healthy during his daily work to provide essential prevention and treatment services, he is also serving his community by participating in the ongoing therapeutic efficacy study (TES) at Ngoma Health Center in the Nyaruguru District of Rwanda.
This therapeutic efficacy study is analyzing the use of two antimalarial drugs to treat malaria among children from 6 months-14 years old to determine which is more effective. Growing resistance to antimalarial drugs used to prevent and treat malaria is a major obstacle to global efforts to reach elimination. These efficacy studies assess and evaluate the effectiveness of treatments and drugs in various combinations to understand how well they combat malaria. This ultimately contributes to comprehensive malaria case management efforts and the global monitoring of antimalarial drug resistance. Bonaventure recently took three sick children to the Ngoma Health Center to participate, including 2-year-old Iradukunda pictured above.
Community health workers, or mugangas, are fundamental to the national workforce for delivering quality malaria services and reaching communities beyond brick-and-mortar health facilities. They contribute to reducing the shortage of health personnel and to improving access to maternal and child health services delivery, including malaria case management at the community level. They are trusted by their communities to provide essential health services. Equipping them with knowledge about the ongoing study and access to bring patients to participate supports a successful outcome.
There are 128 community health workers across 32 villages that support Ngoma Health Center. All of them were trained about the goal of the study, the importance of their role, and the inclusion criteria for patients. Gathering at Ngoma Health Center, they meet monthly to discuss progress and strategize to enroll more patients. So far, 53 children have participated in the study according to Valens Ntaganira, Head of the Ngoma Health Center, who shared “community health workers do an excellent job. More than 90% of enrolled study participants are sent by them.”
The results of therapeutic efficacy studies may be used by Ministries of Health to develop or update national malaria treatment strategies and policies. The World Health Organization recommends that all countries establish and maintain a routine, regular monitoring practice such as a therapeutic efficacy study to track the effectiveness of their primary antimalarial treatment and monitor resistance.
In the last year, PMI Impact Malaria and partners have been providing support to national malaria programs in Burkina Faso, Cameroon, Côte d’Ivoire, DRC, Kenya, Mali, Niger, Rwanda, and Sierra Leone to better understand drug resistance and contribute to global knowledge to combat resistance and work towards elimination. “[Ending malaria] is a humanitarian responsibility,” said Bonaventure, “and [by supporting this study] I am proud to be of service to my community.”
With overarching commitments to flexibility in our work, and greater wellbeing for our employees, we want to ensure PSI is positioned for success with a global and holistic view of talent. Under our new “work from (almost) anywhere,” or “WFAA” philosophy, we are making the necessary investments to be an employer of record in more than half of U.S. states, and consider the U.S. as one single labor market for salary purposes. Globally, we recognize the need to compete for talent everywhere; we maintain a talent center in Nairobi and a mini-hub in Abidjan. PSI also already works with our Dutch-based European partner, PSI Europe, and we’re creating a virtual talent center in the UK.
Affirmative Action and Equal Employment Opportunity
PSI does not discriminate against any employee or applicant for employment because of race, color, religion, sex, sexual orientation, gender identity, national origin, age, marital status, genetic information, disability, protected veteran status or any other classification protected by applicable federal, state or local law. Read our full affirmative action and equal employment opportunity policy here.
PSI is committed to serving all health consumers with respect, and strives for the highest standards of ethical behavior. PSI is dedicated to complying with the letter and spirit of all laws, regulations and contractual obligations to which it is subject, and to ensuring that all funds with which it is entrusted are used to achieve maximum impact on its programs. PSI provides exceptionally strong financial, operational and program management systems to ensure rigorous internal controls are in place to prevent and detect fraud, waste and abuse and ensure compliance with the highest standards. Essential to this commitment is protecting the safety and well-being of our program consumers, including the most vulnerable, such as women and children. PSI maintains zero tolerance for child abuse, sexual abuse, or exploitative acts or threats by our employees, consultants, volunteers or anyone associated with the delivery of our programs and services, and takes seriously all complaints of misconduct brought to our attention.
Diversity and Inclusion
PSI affirms its commitment to diversity and believes that when people feel respected and included they can be more honest, collaborative and successful. We believe that everyone deserves respect and equal treatment regardless of gender, race, ethnicity, age, disability, sexual orientation, gender identity, cultural background or religious beliefs. Read our commitment to diversity and inclusion here. Plus, we’ve signed the CREED Pledge for Racial and Ethnic Equity. Learn more.